<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mallampalli RK</submitter><funding>BLRD VA</funding><funding>NHLBI NIH HHS</funding><pagination>5247-55</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3845358</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>191(10)</volume><pubmed_abstract>Cytokine-driven inflammation underlies the pathobiology of a wide array of infectious and immune-related disorders. The TNFR-associated factor (TRAF) proteins have a vital role in innate immunity by conveying signals from cell surface receptors to elicit transcriptional activation of genes encoding proinflammatory cytokines. We discovered that a ubiquitin E3 ligase F box component, termed Fbxo3, potently stimulates cytokine secretion from human inflammatory cells by mediating the degradation of the TRAF inhibitory protein, Fbxl2. Analysis of the Fbxo3 C-terminal structure revealed that the bacterial-like ApaG molecular signature was indispensible for mediating Fbxl2 disposal and stimulating cytokine secretion. By targeting this ApaG motif, we developed a highly unique, selective genus of s</pubmed_abstract><journal>Journal of immunology (Baltimore, Md. : 1950)</journal><pubmed_title>Targeting F box protein Fbxo3 to control cytokine-driven inflammation.</pubmed_title><pmcid>PMC3845358</pmcid><funding_grant_id>I01 BX002200</funding_grant_id><funding_grant_id>R01 HL112791</funding_grant_id><funding_grant_id>R01 HL116472</funding_grant_id><funding_grant_id>R01 HL098174</funding_grant_id><funding_grant_id>R01 HL097376</funding_grant_id><funding_grant_id>R01 HL01916</funding_grant_id><funding_grant_id>R01 HL096376</funding_grant_id><pubmed_authors>Dunn SR</pubmed_authors><pubmed_authors>Glasser JR</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Coon TA</pubmed_authors><pubmed_authors>Chen BB</pubmed_authors><pubmed_authors>Weathington NM</pubmed_authors><pubmed_authors>Zou C</pubmed_authors><pubmed_authors>Mallampalli RK</pubmed_authors><pubmed_authors>Zhao J</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeting F box protein Fbxo3 to control cytokine-driven inflammation.</name><description>Cytokine-driven inflammation underlies the pathobiology of a wide array of infectious and immune-related disorders. The TNFR-associated factor (TRAF) proteins have a vital role in innate immunity by conveying signals from cell surface receptors to elicit transcriptional activation of genes encoding proinflammatory cytokines. We discovered that a ubiquitin E3 ligase F box component, termed Fbxo3, potently stimulates cytokine secretion from human inflammatory cells by mediating the degradation of the TRAF inhibitory protein, Fbxl2. Analysis of the Fbxo3 C-terminal structure revealed that the bacterial-like ApaG molecular signature was indispensible for mediating Fbxl2 disposal and stimulating cytokine secretion. By targeting this ApaG motif, we developed a highly unique, selective genus of s</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Nov</publication><modification>2025-04-04T12:27:01.284Z</modification><creation>2019-03-26T23:43:01Z</creation></dates><accession>S-EPMC3845358</accession><cross_references><pubmed>24123678</pubmed><doi>10.4049/jimmunol.1300456</doi></cross_references></HashMap>